Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Kandi's Xinchu becomes authorized distributor for Schneider Electric, boosting AI data center power solutions.

Company Fundamentals
01 Jul 2026
Not Specified
View Source
Bullish
pluang ai news

Kandi Technologies' subsidiary Xinchu New Energy has been named an authorized distributor for Schneider Electric in China for 2026. This allows Xinchu to distribute Schneider Electric's UPS systems and related products, enhancing its ability to provide integrated power solutions for AI data centers and telecommunications. The partnership strengthens Kandi's position in the AI data center backup power and energy storage market by improving access to key products and supply chain resources. Kandi aims to expand its presence in AI infrastructure and new energy applications through this collaboration.

More News

Deadlines set for lead plaintiff appointments in class action lawsuits against BitGo, ADMA Biologics, and Erasca.

Deadlines set for lead plaintiff appointments in class action lawsuits against BitGo, ADMA Biologics, and Erasca.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. The lawsuits allege these companies made false or misleading statements affe...

Market News
Bearish
22 minutes ago
Ocular Therapeutix to present new retinal disease data at July 2026 scientific and investor conferences

Ocular Therapeutix to present new retinal disease data at July 2026 scientific and investor conferences

Ocular Therapeutix announced its participation in multiple scientific and investor conferences in July 2026, including presentations on its investigational retinal drug AXPAXLI and real-world data on anti-VEGF treatments. Key events include the OIS R...

Others
Neutral
22 minutes ago
Step Pharma appoints Neil Gallagher as Non-Executive Director to boost cancer drug development.

Step Pharma appoints Neil Gallagher as Non-Executive Director to boost cancer drug development.

Step Pharma has appointed Neil J. Gallagher, MD, PhD, as a Non-Executive Director to strengthen its board as it advances dencatistat, a first-in-class CTPS1 inhibitor targeting essential thrombocythaemia, lymphoma, and solid tumours. Gallagher brings...

Company Fundamentals
Bullish
22 minutes ago
Gaming and Leisure Properties sets Q2 2026 earnings release for July 30 with a conference call on July 31.

Gaming and Leisure Properties sets Q2 2026 earnings release for July 30 with a conference call on July 31.

Gaming and Leisure Properties, Inc. announced it will release its second quarter 2026 financial results after market close on July 30, 2026. The company will hold a conference call on July 31, 2026, at 10:00 a.m. ET to discuss the results and recent ...

Company Fundamentals
Neutral
22 minutes ago
GlobalFoundries schedules Q2 2026 earnings call for August 5, 2026

GlobalFoundries schedules Q2 2026 earnings call for August 5, 2026

GlobalFoundries announced it will hold a conference call on August 5, 2026, at 8:30 a.m. ET to discuss its second quarter 2026 financial results. Investors and interested parties can join the call by registering online, and the webcast will be availa...

Company Fundamentals
Neutral
22 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App